Community Blood Center of the Ozarks Selects BBCS’ ABO Suite as their BECS Provider
October 19, 2016
AUBURN, WA – October 19th, 2016 – Blood Bank Computer Systems, Inc. (BBCS) today announced a new partnership with Community Blood Center of the Ozarks (CBCO). CBCO will be implementing the ABO Suite of products, provided by BBCS, to improve their donor experience and overall operations at each of their facilities. CBCO provides blood and blood products to hospitals throughout Southwest Missouri, Northwest Arkansas and Southeast Kansas. They draw 60,000 units annually from their 4 blood center locations and various mobile drives.
Using ABO Suite, donors will be able to answer the Donor History Questionnaires online at home, reducing their time spent at the blood center. Additionally, ABO Suite will modernize the blood component lab, distributions, billing and other operational departments at CBCO.
“BBCS has a well-documented history of success working with blood centers to implement and upgrade their blood establishment computer systems. Their reputation of great products and over the top commitment to client satisfaction made them a clear choice for our organization as we move to modernize our operations,” says Anthony Roberts, Executive Director of Community Blood Center of the Ozarks.
BBCS will be providing Implementation Services throughout the project to ensure timelines are met and the guidelines set forth in the FDA Code of Federal Regulations are followed throughout the migration to ABO Suite.
“BBCS is thrilled to be chosen as the BECS partner of the future for Community Blood Center of the Ozarks. We are looking forward to adding another strong voice that is committed to the future of blood banking, to our table for our annual CEO Summit in February. The addition of CBCO expands our client base with Alliance for Community Transfusion (ACTS) and moves all of our clients who are Blood Center of America (BCA) members closer to achieving financial savings. We are honored to have CBCO join our growing family,” says Beth Simon, CEO of BBCS.
CBCO joins SunCoast Community Blood Center as the second U.S. based community blood center to purchase ABO Suite through Blood Centers of America (BCA) since a partnership with BCA and BBCS was announced earlier this year. This partnership, geared at growing the BBCS user base, provides financial incentives to BCA members new to BBCS as well as synergies across all BBCS users.
If you are a BCA member and would like more information about this partnership, please contact Nina Salamon of BCA or email BBCS Sales at firstname.lastname@example.org.
For over 30 years, Blood Bank Computer Systems, Inc. (BBCS) has been a dedicated partner to the blood banking industry. BBCS has chosen to remain privately owned to ensure that we can focus on fulfilling our commitments to our clients, the communities that they serve, and the industry. By establishing an annual BBCS CEO Summit, hosting annual meetings with our User Group, and participating in industry conferences we have built rich partnerships with our clients, vendors, and industry organizations.
Since 1995, Community Blood Center of the Ozarks has met the transfusion needs of patients throughout the Ozarks. Each day, they deliver more than 250 blood donations to meet the needs of patients in the thirty-nine hospitals supplied by CBCO. CBCO is a not-for-profit organization committed to providing the highest quality blood and blood products to their area hospitals at the lowest possible cost.
BCA is a member-owned organization comprised of nearly 50 independent blood centers geographically dispersed throughout the North America, representing over 30 percent of the U.S. blood supply. Along with their core business of providing a substantial portion of U.S. blood supply, BCA members provide a variety of other services including, patient blood management, transfusion services, immunohematology testing, therapeutic apheresis and tissue and cord blood banking. In addition, BCA members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries.